System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Prof François R Jornayvaz, MD is an expert in Endocrinology at University Hospital of Geneva (Switzerland). As of November 2026, ScienceLeadR ranks François R Jornayvaz in the top 1% of experts worldwide for Glucose Metabolism Disorders and Diabetes Mellitus. François R Jornayvaz has authored 221 publications, the most recent in 2026, and is an investigator in 4 clinical trials. SLR score: 712 (community average: 125). How the SLR is computed.

LeadR Profile

Prof François R Jornayvaz, MD University Hospital of Geneva Switzerland
712 ScienceLeadR Reputation 712

Unlock

Register Login
Network Map

Endocrinology

Subspecialties: Cardiology - Biochemistry - Hepatology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2004 - 2026
Source: PubMed

University Hospital of Geneva

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 221

Citations

Citations: 9 805 1st author: 23 Last author: 81 Unique author: 18

Main journals

Rev Med Suisse 64
Revue Médicale Suisse 19
Endocr Connect 4
Endocrine Abstracts 4
Proc Natl Acad Sci U S A 4

Best Journals

Eur Heart J 2
JAMA 1
N Engl J Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
[Management of type 2 diabetes in older adults : a subtle balance].
PMID 42958974 — diabetes mellitus, therapeutics, diabetes mellitus, type 2		Rev Med Suisse20260
Adhésion thérapeutique dans le diabète de type 2 : état des lieux.
PMID 42210832 — tissue adhesions		Rev Med Suisse20260
[Corticosteroid-induced diabetes : diagnostic and therapeutic challenges].
PMID 42210835 — diabetes mellitus, glucocorticoids, insulin, adrenal cortex hormones, hyperglycemia, therapeutics		Rev Med Suisse20260
[Diabetology : what's new in 2025].
PMID 41540862 — therapeutics		Rev Med Suisse20260
Interleukin-18 binding protein deficiency results in gut microbiota dysbiosis and aggravated diet-induced MASH in mice.
PMID 41480237 — dysbiosis, gtp-binding proteins, tumor necrosis factor-alpha, housing, proteobacteria, fibrosis, non-alcoholic fatty liver disease, liver, diet, protein deficiency, bacteria, gastrointestinal microbiome, interleukin-18, microbiota		JHEP Rep20250

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 2
Phase 3 1
Phase 4 1

By status:

Completed 4

By type:

Interventional 4

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 1
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS